SKI Market

Indian Indices

Sensex

77,566.16 -1,352.74
( -1.71%)

Global Indices

Nasdaq

47,737.88 215.33
(0.45%)

Dow Jones

6,814.47 53.45
(0.79%)

Hang Seng

52,808.52 -2,812.32
(-5.06%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Anthem Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544449

INE0CZ201020

50.8006126

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ANTHEM

61.8

37073.11

EPS(TTM)

Face Value()

Div & Yield %

10.68

Back

avenuesai ltd

Exide Industries consolidated net profit rises 23.72% in the December 2025 quarter

Jan 30,2026

Net profit of Exide Industries rose 23.72% to Rs 194.01 crore in the quarter ended December 2025 as against Rs 156.81 crore during the previous quarter ended December 2024. Sales rose 4.58% to Rs 4200.59 crore in the quarter ended December 2025 as against Rs 4016.72 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	4200.59	4016.72	5
OPM %	10.76	10.57	-
PBDT	442.83	383.05	16
PBT	293.50	238.02	23
NP	194.01	156.81	24

77,566.16 -1,352.74 ( -1.71%)

47,737.88 215.33 (0.45%)

6,814.47 53.45 (0.79%)

52,808.52 -2,812.32 (-5.06%)

10,249.54 -35.21 (-0.34%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)